FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study finds primary-care doctors often overlook prostate cancer risk in Black men

2.

Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.

3.

FDA Approves New Drug Combo for RR Multiple Myeloma

4.

Year in Review: Chronic Lymphocytic Leukemia

5.

What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot